[Research Results] Press Release (in Japanese)

Clinical Trial (Phase 1) of a New Universal Influenza Vaccine Candidate Formulation Begins

[Research Results] Press Release (in Japanese)

Evaluation of Immune Response to COVID-19 mRNA Vaccine in Liver Transplant Patients - Importance of Additional Vaccination under Immunosuppressive Drugs

Updated news/members etc.

[Research Results] Published in a scientific journal for the general public.

Nikkei Biotech, "VLPT Japan Confirms Antigenicity, etc. in Phase I of Self-Propagating mRNA Vaccine for New Coronas,"

[Research Results] Published in Newspaper

Asahi Shimbun, "Small Doses of "Autologous" Corona Vaccine Prolong Immunity, Clinical Trial Results Released,"

[Research Results] Published in Newspaper

Nihon Keizai Shimbun, "Type A Influenza General-purpose Vaccine to be developed by Sumitomo Pharma and others," morning edition (Osaka), page 12

[Research Results] Published in Newspaper

The Yomiuri Shimbun, "'Universal Vaccine' for Influenza A Targeted for Commercialization in Late 20s," morning edition (Osaka), page 12.

[Research Results] Published in Newspaper

Yomiuri Shimbun, "Influenza 'Universal Vaccine' for Type A Virus Mutation," evening edition (Osaka), page 1

[Research Results] Published in a scientific journal for the general public.

Nikkei Biotech, "New cell soder with 78 fluorescent colors and imaging,"

[Research Results] Press Release.

Elucidating the mechanism of action of a new universal influenza vaccine candidate formulation

[Research Results] Published in Newspaper

The Yomiuri Shimbun, "Corona Vaccine Under Development in Japan Maintains Immunity for One Year. Possibility of extending immunization interval," Evening Edition (Osaka)

[Research Results] Published in Newspaper

Jiji Press, "Replicon (next-generation mRNA) vaccine expressing RBDs on the cell membrane surface successfully induces broad and sustained immunity to a novel coronavirus infection (COVID-19) mutant strain,"

[Research Results] Press Release.

Replicon (next-generation mRNA) vaccine expressing RBDs on the cell membrane surface successfully induces broad-spectrum and sustained immunity against a novel coronavirus infection (COVID-19) mutant strain: Potential application as a basic technology against other pandemic pathogenic viruses

Click here for the press release article.

Click here to see the news release article.

We have renewed our website.

[Research Results] Press Release.

Establishment of a Prediction Model for Safety and Efficacy of Immunostimulants Using High-Parameter Flow Cytometry and Machine Learning -Expectations for Application to the Development of Immunostimulants and Vaccine Adjuvants for Personalized and Stratified Cancer Immunotherapy

Click here for more information

Updated news/members etc.

Updated news/members etc.

Dr. Yamamoto attended a press conference in FCCJ, entitiled "Developing next-generation vaccines for COVID-19 and beyond", with collaborators. The presentation and Q&A are on FCCJ YouTube channel.

Dr.Nogimori gave a presentation at 5th Workshop on Theoretical Immunology.

Dr.Yamamoto and Dr. Takahama gave a presentation at The 34rd Annual Meeting of the Japanese Society for AIDS Research.(Kumamoto/Japan).

Mr. Murakami gave a presentation at The 24th Annual Meeting of the Japanese Association of Cancer Immunology (Sapporo/Japan and Web Hybrid).

科研費研究活動スタート支援（インフルエンザ抗原特異的記憶B細胞を標的とする新規ワクチンアジュバントの開発 代表 野木森）に採択されました。

Mr. Higashiguchi and Mr. Murakami gave a presentation at The 79th Annual Meeting of the Japanese Cancer Association (Hiroshima/Japan and Web Hybrid).

The project of COVID-19 Vaccine, headed by the VLP Therapeutics Japan, was awarded the AMED fund for development of a prophylactic vaccine against SARS-CoV-2. We are happy to be in the team. Detail here.

Updated our list of members and list of achievements.

Sumitomo Dainippon Pharma and National Institutes of Biomedical Innovation, Health and Nutrition Conclude Joint Research Agreement for Universal Influenza Vaccine. Detail here.

Updated our list of members and list of achievements.

Dr. Yamamoto gave a presentation at "U.S.-Japan Cooperative Medical Sciences Program's 22nd International Conference On Emerging Infectious Diseases In The Pacific Rim"（Bangkok/Thai） URL

New office opened.

Dr. Yamamoto gave a presentation at The 48th Annual Meeting of the Japanese Society for Immunology (Hamamatsu/Japan) URL

Dr. Takahama and Mr. Masuta gave a presentation at The 42th Annual Meeting of the Molecular Biology Society of Japan (Hakata/Japan).URL

Dr. Takahama gave a presentation at The 23rd Annual Meeting of the Japanese Society for Vaccinology (Tokyo/Japan).URL

Dr. Takahama and Mr. Masuta gave a presentation at The 33rd Annual Meeting of the Japanese Society for AIDS Research.(Kumamoto/Japan).URL

Updated our list of members.

Dr. Takahama gave a presentation at The 67th Annual Meeting of the Japanese Society for Virology (Tokyo/Japan).URL

Dr. Takahama gave a poster presentation at the 17th Congress of the International Union of Immunological Societies (Beijing/China).URL

Dr. Yamamoto gave a presentation at the France-Japan Symposium: "Implication of senescence in age-related disorders: towards healthy aging" (Paris/France).

Updated our list of members and list of achievements.

Established our website.